CINXE.COM

<!DOCTYPE html> <html lang="en"><head> <meta charset="utf-8"> <title>Instructions for Authors</title> <meta name="viewport" content="width=device-width, initial-scale=1" > <link rel="stylesheet" type="text/css" media="all" href="/ms/css/ivy.css?v=81"> <link rel="stylesheet" type="text/css" media="all and (min-width: 801px)" href="/ms/site/mainnew.css?v=13"> <link rel="stylesheet" type="text/css" media="all and (min-width: 801px)" href="/style.css?v=35"> <link rel="stylesheet" type="text/css" media="all and (max-width: 800px)" href="/ms/css/ivymobile.css?v=34" > <link rel="stylesheet" type="text/css" media="all and (max-width: 800px)" href="/ms/site/sitemobile.css?v=2" > <script src="/ms/java/function.js?v=43"></script> </head> <body id="main_body"> <div id="page_all"> <div id="container"> <div id="header"> <div id="logo"> <div > <span class='button_grey impactfactor'>Impact factor<br>3.3</span><span class='display_pc' > <br><br><br><br></span> <span class='textlinkgrey display_pc' >ISSN: 1837-9664</span><span class='ivyjournal display_mobile'>Journal of Cancer</span> </div> </div> <div id="key_visual"> </div> </div> <div id="main_nav_container"> <ul id=main_nav_list><li><a href="/" >Home </a></li><li><a href="/about" >About </a></li><li><a href="/ms/author" class='current' >For Authors </a></li><li><a href="/ms/submit" >Submit Manuscript </a></li><li><a href="/ms/status" >Login </a></li><li><a href="/ms/feedback" >Contact </a></li></ul> <div class='topnav-right'> <a href='/ms/userlogin' title='My account'><img src='/ms/images/account.svg' alt='Account' height='24' width='24'> </a> </div> </div> <div id="main_container"> <div id="sub_container1"> <div id="sub_nav_container"> <ul class='sub_nav_list'><li><a href="/currentissue" >Current Issue </a></li><li><a href="/ms/archive/16" >Volume 16; 2025 </a></li><li><a href="/ms/archive/15" >Volume 15; 2024 </a></li><li><a href="/ms/archive/14" >Volume 14; 2023 </a></li><li><a href="/ms/archive/13" >Volume 13; 2022 </a></li><li><a href="/ms/archive/12" >Volume 12; 2021 </a></li><li><a href="/ms/archive" >Archive </a></li><li><a href="/editorial" >Editorial Board </a></li><li><a href="/ms/coverimage" >Cover Images </a></li><li><a href="/indexrank" >Index & Coverage </a></li><li><a href="/specialissue" >Special Issues </a></li></ul> <form method="post" action="/ms/mysearch" class="searchblock" > <input type="text" name="query" size="9" maxlength="255" value="" id="sbi" class="formfield" placeholder="Article title/doi"> <button type="submit" name="search" value="Search" id="sbb" title="Search article by title or doi"><img src='/ms/images/search.svg' alt='Search' height='24' width='24' style='vertical-align: middle;'></button> <input type="hidden" name="content" value="JCA1837-9664"> </form> <div class='sub_nav_space display_pc'></div> <div class="textcenter"> <p class="divboxbg"><a href="https://www.ijbs.com" class="textlink">International Journal of Biological Sciences</a></p> <p class="divboxbg"><a href="https://www.medsci.org" class="textlink">International Journal of Medical Sciences</a></p> <p class="divboxbg"><a href="https://www.thno.org" class="textlink">Theranostics</a></p> <p class="divboxbg"><a href="https://www.jgenomics.com" class="textlink">Journal of Genomics</a></p> <p class="divboxbg"><a href="https://www.ntno.org" class="textlink">Nanotheranostics</a></p> <a href="https://www.ncbi.nlm.nih.gov/pmc/journals/1305/" ><img src="/ms/images/pmclogo.gif" alt="PubMed Central" width="145" height="75" class="imagecenter" ></a> <p class="divboxbg abstract"> <img src="/ms/images/openaccess.jpg" width="145" height="54" alt="open access"> Global reach, higher impact</p> </div> </div> </div> <div id="sub_container2">  <div class ='vlistshow sticky righboxfix' ><ul><li><a href="#fee" >Publication Fee</a></li><li><a href="#submission" >Submission</a></li><li><a href="#license" >License</a></li><li><a href="#pubformat" >Format</a></li><li><a href="#reference" >Ref./EndNote</a></li><li><a href="#top" >Top</a></li> </ul> </div> <h1 id="top">Instructions for Authors</h1> <p>Journal of Cancer welcomes submissions of research papers, reviews, and short research communications in all cancer-related fields. We particularly welcome high-quality reviews from leading researchers, which will be given priority in processing.</p> <p>Note: Case reports and articles with limited case series will not be considered for publication. Please refrain from submitting case reports, case series, or case reviews.</p> <p>The journal does not impose a specific length limit on research papers and reviews; however, authors are encouraged to be concise. Short research communications should be no longer than 2,500 words. For regular research papers, we recommend organizing the manuscript as follows: Abstract, Introduction, Materials and Methods, Results, Discussion, followed by Acknowledgements, Conflict of Interest, and References.</p> <h2>Authorship</h2> <p>Each author listed on a manuscript submitted to this journal must adhere to the four authorship criteria set by the International Committee of Medical Journal Editors (ICMJE):</p> <ol> <li>Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND</li> <li>Drafting the work or revising it critically for important intellectual content; AND</li> <li>Final approval of the version to be published; AND</li> <li>Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.</li> </ol> <h2>Plagiarism</h2> <p><strong>Plagiarism Policy (please read before submission)</strong>: Our journal has a <strong>zero-tolerance policy</strong> towards plagiarism, including self-plagiarism. Manuscripts are screened for plagiarism before, during, and after publication. If plagiarism is detected at any stage, the manuscript will be rejected. If a published paper appears in PubMed Central and plagiarism is later detected or reported by experts, the paper will be retracted, and the authors' institutions and department heads will be notified to take appropriate action. This policy also covers data fabrication, data falsification, and image manipulation.</p> <h2 id="submission">Submission</h2> <p>★ To submit a new manuscript, please use the <a href="/ms/submit?submissiontype=new">new submission</a> link. </p> <p>★ To submit a revision, please <a href="/ms/status">log in</a>, select your manuscript, and click the 'Submit Revision' link. Do not submit a revision as a new manuscript. </p> <p>All files must be uploaded directly to the journal's website. Manuscripts submitted via email (either to the editors or the journal office) will not be accepted and will be automatically discarded.</p> <p>The submitting author must be the corresponding author or one of the corresponding authors.</p> <p>Please embed figures and tables within the manuscript to create a single file (Word or PDF) for submission. After submission, the system will generate a manuscript ID, which will be sent to the corresponding author's email.</p> <p><strong>Supplementary Files:</strong> During the initial submission, you may upload one supplementary file along with the main manuscript and cover letter. Additional supplementary files can be uploaded after the initial submission via the <a href="/ms/status">manuscript login</a> page by clicking the "[Add More]" link under the 'Supplementary File' section. Large files should be compressed into a ZIP file (RAR files will not be accepted). To create a ZIP file in Windows, first select the files, then right-click and choose "Send to > Compressed (zipped) folder." Supplementary materials will be linked to the paper online and will not be edited.</p> <p>Manuscripts previously posted on preprint servers (e.g., BioRxiv, MedRxiv, ChemRxiv) may be submitted to our journal. Authors can also post their manuscripts to other preprint servers if the manuscripts are accepted by our journal.</p> <h2 id="review">Review/Decisions</h2> <p>Manuscripts that are deemed to be of insufficient quality or unlikely to be competitive for publication are rejected during the initial screening. Remaining manuscripts undergo a single-blind peer review process with two or more reviewers. In single-blind review, the reviewers' identities are concealed from the authors, but not vice versa. After the review, possible decisions include: accept as is, minor revision, major revision, or rejection. Authors should submit their revisions within 1 months for minor revisions or 3 months for major revisions. If more time is needed, please contact the editor-in-charge for an extension. Manuscripts with significant results are typically prioritized for review and publication. </p> <p><strong><em>Note:</em></strong>聽Once the manuscript is accepted, any publishing-related inquiries (such as copyediting, fees, proofs, etc.) should be directed to <a href="/ms/feedback">our publishing team</a> only. Please do not send or cc such inquiries to the editor-in-chief or editors, as they are not involved in the publishing process after acceptance. </p> <h2 id="license">License</h2> <p>Articles in our journal are now distributed under the Creative Commons Attribution International License (<a href="https://creativecommons.org/licenses/by/4.0/">CC-BY license</a>). Authors retain copyright of their articles.</p> <p>For articles published prior to June 10, 2019, the default license was the Creative Commons Attribution-NonCommercial License (<a href="https://creativecommons.org/licenses/by-nc/4.0/">CC BY-NC license</a>), with copyright held by the publisher. Please refer to the copyright and open access statement for each individual article.</p> <h2 id='fee'>Publication Fee</h2> <p>Publication fees are payable only if a manuscript is accepted for publication. There is no additional charge for color figures, nor is there a submission fee. Payment instructions will be provided during the publication process, and an invoice will be available on the <a href='status'>manuscript login</a> page after acceptance. Payments can be made via credit card (Visa/MasterCard/UnionPay<img src='/ms/images/new.gif' alt='new' >) or bank transfer. The publication fee is required to cover the cost of publication and must be paid before copyediting, and within 3 months of acceptance. </p> <table class='ivytablelight'> <tr> <td >Research paper/<br> Review/<br> Short research communication/<br> Erratum/<br> Others</td> <td >$AUD 3500</td> </tr> <tr> <td>Letter</td> <td>$AUD 1750</td> </tr> </table><p>* $AUD: Australian dollar. <a href='https://www.xe.com/currencyconverter/convert/?Amount=3500&From=AUD&To=USD'>Currency Converter</a> (external source)</p> <img class='clickfig' src='/ms/images/thnov06p2414toc.jpg' alt='Graphic abstract sample' onclick="openPopupFig('/ms/images/thnov06p2414toc.jpg');"> <h2 id="GraphicalAbstract">Graphical Abstract</h2><p>Authors are encouraged to provide a graphical abstract (a visually striking figure) to represent the paper and attract the attention of readers. The graphical abstract will be published online in the table of contents. It should be colorful and fit within a 12 cm (width) x 6 cm (height) area. The image must have a minimum resolution of 600 dpi for standard images and 1200 dpi for line art. Note: The height should not exceed half the width. To maintain clarity in the small space, please avoid overcrowding the graphical abstract with excessive information. Accepted formats include JPG (preferred), PDF, Word, PowerPoint, or PNG. A graphical abstract is not required at the initial submission, but it is mandatory at the revision or publication stage. See more sample graphical abstracts in <a href="https://www.thno.org">https://www.thno.org</a>. </p>  <h2 id="pubformat">Format for Publication</h2> <p>Once a manuscript is accepted, authors must submit the final version in Microsoft Word format, following the guidelines provided, for copyediting and publication. Please note that we cannot accept LaTeX or TeX files.</p> <p>Figures should be included at the end of the manuscript in the Word file. Additionally, you may submit a high-quality PDF containing all figures, with each figure on a separate page. Ensure that images are of the highest resolution, with clear and legible text. If figures or tables were created using programs like PowerPoint, Photoshop, or Microsoft Excel, please also include the original files from those programs.</p> <h3 id="titleformat">Title Page</h3> <p>The first letter of each word in the title should be capitalized. On the first page, include the article title, authors' full names, affiliations, and the corresponding author's phone/fax number and/or email address. Additionally, provide 3-6 keywords.</p> <p>The abstract should not contain citations, images, or mathematical equations. </p> <p>Author names should be provided in full. <strong>Important:</strong> Write the first and middle names before the surname (e.g., 'Mike Johnson'), not 'Johnson, Mike,' 'Johnson M.,' or 'M. Johnson.'</p> <p><strong>Authorship</strong>: The list of authors and contributors must adhere to the guidelines established by the International Committee of Medical Journal Editors (ICMJE). </p> <h3>Web pages and Web links</h3> <p>We strongly discourage mentioning or citing web links/URLs in your manuscript, as web addresses are frequently changed by their owners. This often results in broken (dead) links, which can frustrate readers.</p> <h3>Text</h3> <p>In the main text or figure/table legends, please avoid coloring the font to distinguish text or using smaller or larger font sizes. Only bold, italic, superscript, and subscript are allowed in our XML format.</p> <p>Please do not number subtitles (except in Review or Mini-Review articles).</p> <h3>Tables and Figures</h3> <p>Tables and figures should be numbered consecutively. Cite tables and figures using the format: Table 1, Table 2, ... Figure 1, Figure 2, ... (or Fig. 1, Fig. 2, ...). Parts of a figure should be labeled as A, B, C, D, etc., and cited as Figure 2A, Figure 2B, Figure 2C. Please do not abbreviate "Table" as "Tab."</p> <p>Tables: Create tables using Microsoft Word's table format. Tables must be editable and not inserted as images.</p> <p>Figures: Images should have a minimum resolution of 600 dpi, and line art should be at least 1200 dpi. Graphics downloaded from the internet are not acceptable due to their low 72 dpi resolution. Please submit one high-quality PDF containing all figures (one figure per page). Please remove the word "Figure" or "Fig." from the image itself.</p> <h3>Math Formulas and Symbols</h3> <P>Simple mathematical formulas should be typed in normal text using superscript, subscript, italics, and symbols in Microsoft Word.</p> <UL><LI>Use the "Normal Text" or "Symbol" fonts for symbols. To insert a symbol, go to <em>Insert > Symbol</em> in the Word menu. </LI> <LI>For "divide" or "over," use the slash (/) symbol. For example: 1/7, 5/(4+6).</LI> <LI>Use the "Symbol" font for symbols such as "±"; "≤" and "≥" (<em>do not use underline</em>).</LI> </UL> <p><em>Please avoid using Word's equation editor whenever possible</em>. In the full-text XML/HTML version, math equations are converted into images, which disrupts the text flow and may not appear clearly.</p> <h3 id="reference">References </h3> <p>References should be numbered consecutively, starting from 1, and cited in the manuscript using numbers (e.g., [1,2,3]), not by author and date. Each reference should correspond to only one article (e.g., not 1a, 1b, 1c). Personal communications, unpublished observations, conference abstracts, or conference papers should not be included in the reference list. References should be formatted as plain text鈥攄o not use images or mathematical equations.</p> <p><strong>EndNote:</strong> An <a href="/ms/ivyspring.ens">EndNote reference style</a> for our journal can be downloaded. Place the style file in the Windows directory: C:\Program Files (x86)\EndNote X?\Styles (where '?' is the EndNote version number). Afterward, open MS Word and select the "ivyspring" style from the EndNote tab. This style applies to all Ivyspring journals.</p> <p>Please ensure that the total number of references does not exceed 200 for any article.</p> <ul> <li>Journal Paper <br> Use the sequence: [Author surname] [Author initials], [Other author surnames & initials]. [Article title]. [Journal name abbreviation]. [Year]; [Volume]: [First page number]-[Last page number]. <ul> <li> <strong>Journal paper must have journal name (or journal abbreviation), year, volume and page numbers</strong>. <li><em>Please make sure that the year of publication is not missing</em>. <li>Please use ":" to separate volume and first page number. <li>Do not bold or italicize the title, journal name, or any part of references. Omit any "." in the journal abbreviations. </ul> Examples: <UL> <li> 1. Eknoyan G, Beck GJ, Cheung AK, et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med. 2002; 347: 2010-9. <LI><strong>Supplement</strong> example:<BR> 2. Volk HD, Reinke P, Krausch D, et al. Monocyte deactivation-rationale for a new therapeutic strategy in sepsis. Intensive Care Med. 1996; 22 (Suppl 4):S474-S481.</LI> <LI><strong>No author given</strong> example:<BR> 3. [No authors listed]. Medicare program; criteria for Medicare coverage of adult liver transplants-HCFA. Final notice. Fed Regist. 1991; 56(71):15006-15018. </LI> <LI><strong>In press</strong> example:<br> 4. Cheung TMT, et al. Effectiveness of non-invasive positive pressure ventilation in the treatment of acute respiratory failure in severe acute respiratory syndrome. Chest; in press.<b></b></LI> <LI><strong>Epub ahead of print</strong> example:<br> 5. Li W, Chen Y, Cameron DJ, et al. Elovl4 haploinsufficiency does not induce early onset retinal degeneration in mice. Vision Res 2007; [Epub ahead of print].</LI> </UL> </li> <li> Book<ol><li> Kiloh LG, Smith JS, Johnson GF, et al. Physical treatment in psychiatry. Boston, USA: Blackwell Scientific Publisher; 1988.</li> </ol></li> <li>Chapter in Edited Book <ol><li> Beckenbough RD, Linscheid RL. Arthroplasty in the hand and wrist. In: Green DP, ed. Operative Hand Surgery, 2nd ed. New York: Churchill Livingstone; 1988: 167-214.</li> </ol></li> <li>Website (<strong>discouraged</strong>) <ol><li> [Internet] WHO. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. https://www.who.int/</li> <li>[Internet] Kornberg R. https://nobelprize.org/</li> </ol> </li> </ul> <p><strong>DOI</strong>: Please remove the "[pii]" field in any doi. E.g., doi:00932.2006 [pii] 10.1152/japplphysiol.00932.2006. Remove "00932.2006 [pii]".</p> <p><strong>* Please do not add web links or web URLs in references.</strong></p> <h3>Supplementary materials</h3> <p>Supplementary materials may include figures, tables, methods, videos, and other content. These materials will be available online, linked to the original published article. Supplementary tables and figures should be labeled as "S1," "S2," etc. (e.g., Table S1, Figure S1, Video S1) and cited in the manuscript the same way. Do not refer to them as "S Table 1" or "S Figure 1."</p> <p>The maximum file size for supplementary materials is 10 MB per file (uncompressed). To avoid issues with large file downloads, please keep files as small as possible. Large files can be compressed into a ZIP file (but not RAR).</p> <p>Supplementary materials are published as provided by the authors and are not copyedited.</p> <h3>Abbreviations </h3> <p>Abbreviations should be presented in a single paragraph in the format: "term: definition." Separate items with a semicolon. Please strictly follow this format.</p> <p>Example: HIV: human immunodeficiency virus; SIV: simian immunodeficiency virus; ...</p> <h3 id="headbio2">Author Biography</h3> <p>Authors have the option to include a biography with their paper, detailing information such as MD/PhD degrees, past and current positions, research interests, awards, and more. This helps increase the authors' visibility and is well received by international readers. The author biography should be added at the end of the paper under the section heading 'Author Biography.' For reference, see <a href="https://www.thno.org/v02p0283.htm#coraddress">Sample A</a> or <a href="https://www.ijbs.com/v05p0192.htm#coraddress">Sample B</a>. </p> <h2 id="archiving">Archiving</h2> <p>Our journal is fully open-access, with articles freely available on the journal website, including PDF, XML, and supplementary materials (if applicable). All published articles are permanently archived by <a href="https://www.ncbi.nlm.nih.gov/pmc/">PubMed Central</a> (U.S. National Library of Medicine) and <a href="https://europepmc.org/">Europe PMC</a>. Authors are also encouraged to self-archive their published articles on their personal or institutional websites, as well as governmental or library platforms, without needing permission.</p> <h2 id="AItool">Artificial Intelligence (AI) tools</h2> <p>In accordance with COPE guidelines, if any AI tool (such as ChatGPT) is used in the manuscript鈥攚hether for writing, generating images, collecting data, or analyzing data鈥攁uthors must fully disclose this in the Acknowledgements section. Additionally, the Materials and Methods section should specify how the AI tool was used, which tool was used, and which parts of the manuscript (text or images) were affected. Please note that AI tools cannot be listed as authors of the manuscript.</p> <h2 id="ethicsapproval">Ethics Committee Approval and Patient Consent </h2> <p>Experimental research involving humans or animals must be approved by the author’s institutional review board or ethics committee. This approval should be mentioned in the manuscript, including the name of the board/committee. Research involving human subjects must adhere to the principles of the <a href="https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/">Declaration of Helsinki</a>. Authors should also comply with the <a href="https://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/clinical-trial-registration.html">clinical trial registration requirements</a> from the International Committee of Medical Journal Editors, providing the clinical trial registration number.</p> <p>For research involving human subjects, informed consent must be obtained from each participant. The identities and privacy of patients or participants must be fully protected in the manuscript, in line with ICMJE guidelines on <a href="http://www.icmje.org/recommendations/browse/roles-and-responsibilities/protection-of-research-participants.html">Protection of Research Participants</a>.</p> <p>The manuscript should indicate whether informed consent was obtained, either in the Methods section, Acknowledgements, or in a separate section. If informed consent was obtained orally or not obtained, the authors must clearly explain the reasons and provide approval from the institutional review board or ethics committee.</p> <h2 id="conflict">Competing Interests</h2> <p>Competing interests (also known as "conflicts of interest") that may influence the objective presentation of research findings should be disclosed in a paragraph titled "Competing Interests," placed after the Acknowledgments section and before the References.</p> <p>According to the International Committee of Medical Journal Editors, financial relationships鈥攕uch as employment, consultancies, stock ownership or options, honoraria, patents, and paid expert testimony鈥攁re the most easily identifiable and often considered potential conflicts of interest. These can undermine the credibility of the journal, the authors, and science itself. Other potential conflicts may include personal relationships, academic rivalries, intellectual beliefs, or competition. Authors should avoid agreements with study sponsors (both for-profit and non-profit) that restrict access to all study data or hinder the ability to analyze, interpret, and publish the data independently. Policies that limit where authors may publish their work violate academic freedom. Authors may be asked to provide these agreements confidentially.</p> <p>Authors must fully disclose any conflicts of interest. If no conflicts exist, please state: "The authors have declared that no competing interests exist."</p> <h2>Data Availability </h2> <p>Authors are recommended to deposit large datasets in a public repository. Smaller datasets may be published as supplementary materials. Authors may provide the following:</p> <ul> <li>The location and method for accessing the data. If all data are included in the manuscript or supplementary materials, please specify.</li> <li>If the data will be shared upon request, provide detailed contact information.</li> <li>If the data are deposited in a public repository, include the URLs (and DOIs, if available).</li> <li>If the data cannot be shared openly, explain the reasons (e.g., to protect study participants or patient privacy).</li> </ul> <h2 id="ethnics">Publication Ethics</h2> <p>Our journals follow the guidelines set by the Committee on Publication Ethics (COPE) for addressing publication ethics issues. For more details, please visit our dedicated <a href="/ms/ethics"> Publication Ethics</a> page. </p> <h2 id="advertising">Commercial advertising</h2> <p>Commercial advertising is not allowed in our journal.</p> <hr class="hrbluedot" > <p>For general information about preparing biomedical manuscripts, please consult the "Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication", available from <a href="http://www.icmje.org/">http://www.icmje.org/</a>.</p>   <div id="popupFig" class="popupFig cursor-zoom-out"> <div id="popupFig-wrap" class="popupFig-wrap"> <img id="popupFigImage" src="" class="clickfig_max" alt="Popup Image" onclick="closePopupFig()"> </div> </div>  </div> <div id="footer_text"><hr class="nice"> <p>©2025 <a href="https://ivyspring.com" >Ivyspring International Publisher</a>. <a href="/ms/terms">Terms of use</a></p></div> </div> </div> </div> </body></html>